Handelsbanken Fonder AB

Position in RCUS — Arcus Biosciences, Inc.

CIK 1398318 STOCKHOLM, V7

Position in RCUS

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$1,202,370

+$1,007,690 QoQ

Shares Held

39,000

+57.3% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 8 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. RCUS ranks #59 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	218,292	$108,432,185
2	HALO	Halozyme Therapeutics, Inc.	631,899	$49,458,734
3	ARGX	Argenx SE	52,653	$48,849,873
4	RVMD	Revolution Medicines, Inc.	212,275	$39,754,862
5	CYTK	Cytokinetics Inc	405,000	$34,501,950
6	KRYS	Krystal Biotech, Inc.	90,407	$33,601,569
7	REGN	Regeneron Pharmaceuticals, Inc.	52,328	$32,628,601
8	ALNY	Alnylam Pharmaceuticals, Inc.	107,255	$32,286,972

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,202,370	39,000	+57.3%	Shares	Sole	2026-07-10
2025-03-31	$194,680	24,800	0.0%	Shares	Sole	2025-04-15
2024-12-31	$369,272	24,800	+11.2%	Shares	Sole	2025-02-03
2024-09-30	$340,967	22,300	+15.5%	Shares	Sole	2024-10-04
2024-06-30	$293,939	19,300	+50.8%	Shares	Sole	2024-08-05
2024-03-31	$241,664	12,800	0.0%	Shares	Sole	2024-05-13
2023-12-31	$244,480	12,800	+50.6%	Shares	Sole	2024-02-01
2022-09-30	$222,360	8,500	0.0%	Shares	Sole	2022-10-27
2022-06-30	$215,390	8,500	0.0%	Shares	Sole	2022-08-03
2022-03-31	$268,260	8,500	-30.9%	Shares	Sole	2022-05-11
2021-12-31	$497,781	12,300	0.0%	Shares	Sole	2022-02-08
2021-09-30	$428,901	12,300	0.0%	Shares	Sole	2021-11-10
2021-06-30	$337,758	12,300	—	Shares	Sole	2021-08-03
No filing history on record for this holder in this stock.